cangrelor tetrasodium

• CAT Number: M020881
• CAS Number: 163706-36-3
• Molecular Formula: C17H21Cl2F3N5Na4O12P3S2
• Molecular Weight: 864.274
• Purity: ≥95%
• Storage: Store at -20°C
• IUPAC Name: tetrasodium;[dichloro(phosphonato)methyl]-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxyphosphinate
• InChI: InChI=1S/C17H25Cl2F3N5O12P3S2.4Na/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32;;;;/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32);;;;/q;4*+1/p-4/t8-,10-,11-,14-;;;;/m1..../s1
• InChIKey: COWWROCHWNGJHQ-OPKBHZIBSA-J
• SMILES: CSCCNC1=NC(=NC2=C1N=CN2C3C(C(C(O3)COP(=O)([O-])OP(=O)(C(P(=O)([O-])[O-])(Cl)Cl)[O-])O)O)SCCC(F)(F)F.[Na+].[Na+].[Na+].[Na+]

Cangrelor tetrasodium (Cat.No:M020881) is an intravenous antiplatelet medication used during percutaneous coronary intervention (PCI) procedures to prevent blood clot formation. It works by inhibiting the activation of platelets, reducing the risk of stent thrombosis and related complications. Cangrelor tetrasodium provides rapid and reversible platelet inhibition, enhancing PCI safety and efficacy.